We are live on
!
Find out more
ISL
Ingalls & Snyder LLC Portfolio holdings
AUM
$2.83B
1-Year Est. Return
21.61%
This Fund
S&P 500
This Quarter
Est. Return
+7.17%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.85B
AUM Growth
-$202M
(-9.9%)
Cap. Flow
-$288M
Cap. Flow
% of AUM
-15.59%
Top 10 Holdings %
Top 10 Hldgs %
31.04%
Holding
450
New
28
Increased
86
Reduced
211
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$5.86M |
| 2 |
VG
Vonage Holdings Corporation
VG
|
+$4.47M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$1.62M |
| 4 |
Cisco
CSCO
|
+$1.54M |
| 5 |
Simon Property Group
SPG
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$55.1M |
| 3 |
Bank of America
BAC
|
+$21.4M |
| 4 |
Abbott
ABT
|
+$16.5M |
| 5 |
Globe Life
GL
|
+$16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Energy | 16.48% |
| 3 | Industrials | 10.8% |
| 4 | Financials | 10.7% |
| 5 | Technology | 9.23% |
Similar funds
GS
SL
AF
SIC
ADEF
AIP
SAI
FISPB
Ingalls & Snyder LLC's Q4 2019 Portfolio in Review
As of Q4 2019, Ingalls & Snyder LLC held 450 positions worth $1.85B, down 9.9% from $2.05B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ingalls & Snyder LLC withdrew a net $288M in Q4 2019, closing 50 positions and reducing 211 holdings. Its most notable exit was Apple, an estimated $59.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Energy and Industrials.
Against the trend, Ingalls & Snyder LLC opened a new position in ROSETTA STONE INC worth $539K.
- Ingalls & Snyder LLC's largest Q4 2019 buy was ROSETTA STONE INC: 29,710 shares worth $539K.
- Ingalls & Snyder LLC added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.86M increase.
- Ingalls & Snyder LLC's biggest Q4 2019 reduction was Corcept Therapeutics, cutting an estimated $9.71M.
- Ingalls & Snyder LLC fully exited Apple in Q4 2019, selling an estimated $59.2M.
- Ingalls & Snyder LLC's ten largest holdings make up 31% of its $1.85B portfolio in Q4 2019.
- Ingalls & Snyder LLC opened 28 new positions and closed 50 in Q4 2019.
- Ingalls & Snyder LLC's portfolio value fell 9.9% quarter-over-quarter to $1.85B.
Based on Ingalls & Snyder LLC's 13F filing for Q4 2019, filed 15 Jan 2020.